Hologic Inc.

City-funded organization

Hologic Inc. is a medical technology company headquartered in Marlborough, Massachusetts, that makes mammography systems, diagnostic testing platforms, and other imaging and surgical equipment focused on women's health; it traded on Nasdaq as HOLX until Blackstone and TPG agreed to take it private in an $18.3 billion deal announced in October 2025. In New York City it primarily supplies mammography units and related equipment to NYC Health and Hospitals Corporation hospitals, and its Department of Health and Mental Hygiene contract for "testing platforms for detection of HIV, Trichomonas, Zika," ($4,664,523) was awarded sole source. It holds $2.52 million in active city contracts as of August 2026 and has been awarded $19.7 million in city contracts since 2015 across 37 registered contracts, with $18.4 million paid to date. 99% of the contract value awarded to it was won without a fresh competitive bid ($19,545,753 across 35 contracts), per the page's tracked metric.

Industry (per city contracts)
Goods
City contracts (active)
$2,517,152 · 6 contracts
Awarded all-time
$19,691,903 · 37 since 2015, incl. expired
Paid to date
$18,437,409
Won without a fresh bid
99% of contract value · $19,545,753 · 35 contracts
Based in
Marlborough, MA (out of state)

Holds contracts at

City contracts

Registered city contracts, largest first by current contract value (not amount spent): running now, then registered to start later, then ended. Totals count every registered contract. Each line shows its Checkbook contract ID. The tag on each row is how it was awarded (“no-bid” = non-competitive).

Sources